… the effect of bone marrow mesenchymal stem cell (BMSC)-derived exosome injection on
cartilage damage and pain relief in both in vitro and in vivo models of osteoarthritis (OA). …

… Other sequelae included pain, swelling and dehydration after aspiration 15 . A more recent
… of autologous stem cell therapies found they primarily included post-procedural pain or pain …

… The main goals of traditional medication and biological agents in OA treatment are relief of
pain and slowing down or halting of the progress of OA. Stem cell-based therapy is of great …

Aim Management of osteoarthritis ( OA ) is basically symptomatic. Recently, stem cells ( SC )
have been used in the search for an optimum treatment. We decided to conduct a controlled …

… A clinical trial of autologous bone marrow stem cells (BM-SC) concluded that a single IA
injection of these stem cells significant reduced knee pain and improved quality of life[67]. Other …

… feasibility and safety of osteoarthritis treatment with mesenchymal stromal cells (MSCs) in …
Our results suggest that MSC treatment improves pain and other clinical signs and, in some …

… stem cells (MSCs), as well as freshly isolated bone marrow mononuclear cells (BMMNCs),
on pain, cartilage damage, bone changes and inflammation in an in-vivo rat osteoarthritis (OA…

… and at successive controls: pain on VAS, time to walk to produce pain, number of stairs to
climb to produce pain, the resting time to induce the gelling pain, the range of motion, the …

… Osteoarthritis is one of the most common chronic health problems in the world that causes
disability and chronic pain … , pharmacological intervention for pain management, and surgical …

… stem cells (MSCs) represent a promising biological therapeutic option as an osteoarthritis
(OA)-… repair cells. The effects of intra-articular injection of MSC secretome on OA-related …